Pramlintide acetate is an amylin analogue that is primarily used to treat patients with type 1 and type 2 diabetes. By promoting the secretion of insulin and protecting islet B cells, it helps patients control blood sugar levels and reduces the occurrence of hypoglycemia (refer to relevant literature)
